Rectify Pharma Alternatives & Competitors
12 companies similar to Rectify Pharma — Developing Positive Functional Modulators (PFMs) to restore and enhance membrane...
Companies similar to Rectify Pharma
-logo.jpg "Kineta (Reverse Merger With Yumanity Therapeutics)"){kind=logo}
Kineta (Reverse Merger With Yumanity Therapeutics)
Pioneering new horizons in neurodegenerative disease treatment by addressing protein misfo...
Alector
We are on a mission to make brain disorders history.
South San Francisco, Unit...
CuraSen Therapeutics, Inc.
Targeting neurodegeneration with novel science and treatments so patients can THINK, AGAIN
San Carlos, United States
Dewpoint Therapeutics
Translating condensate biology into medicine.
Boston, United States
Rival Readout
Competing with Rectify Pharma? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Samsara Therapeutics
Treating Neurodegenerative Disease by Restoring Autophagy
Oxford, United Kingdom
Alaunos Therapeutics
Attacking solid tumors with TCRs
Houston, United States
Moonwalk Biosciences
Pioneering novel therapeutics in adipose biology and tissue, driven by deep genetic and ep...
South San Francisco, Unit...
Rapport Therapeutics
Precision medicines to match the complexity of the human brain.
United States
Shanghai, China
Hummingbird Bioscience
Hummingbird Bioscience is a biotherapeutics company working at the interface of AI and hum...
Singapore, Singapore
Montis Biosciences
Pioneering next-gen therapeutics to harness C1q's central role in neuroinflammatory diseas...
Belgium
Biogen
Innovative therapies worldwide for people living with serious neurological and neurodegene...
Cambridge, United States
About Rectify Pharma
Rectify Pharma is a burgeoning player in the biotechnology sector, established with a focus on developing Positive Functional Modulators (PFMs)—a pioneering class of oral, small molecules designed to restore and enhance membrane protein function. The company targets the root causes of serious diseases through their inn...
Development of small molecule therapies, PFM product platform, Orphan disease therapeutics, Drug pipeline development
Healthcare providers, Patients with rare diseases, Medical researchers, Pharmaceutical companies
Positive Functional Modulators, Small Molecule Therapeutics, Membrane Protein Function, Genetic Diseases, Rare Diseases, Cardio-Renal-Metabolic Diseases, Neurodegenerative Diseases, ABC Transporter Restoration, Precision Therapies, Drug Discovery Platform, Liver Diseases, Series A Funding, Atlas Venture, Omega Funds, Disease-Modifying Therapies
B2B, B2D
Licensing, Product Sales, Performance Based
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Rectify Pharma: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Rectify Pharma on 28 Jan 2026. The 12 companies listed here were last checked between 13 Sep 2024 and 16 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
